Alpine Immune Sciences, Inc.
(Deutsche Boerse AG : NVLS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.02%185.181.2%$602.76m
CELGCelgene Corporation
-0.86%78.121.2%$528.03m
GILDGilead Sciences, Inc.
-0.20%70.930.9%$517.61m
BIIBBiogen Inc.
-1.78%290.771.2%$429.53m
NKTRNektar Therapeutics
-2.65%51.455.6%$402.05m
SRPTSarepta Therapeutics, Inc.
-3.69%135.1516.6%$343.22m
VRTXVertex Pharmaceuticals Incorporated
-2.83%154.681.9%$261.64m
REGNRegeneron Pharmaceuticals, Inc.
-2.26%324.472.6%$242.41m
ILMNIllumina, Inc.
-2.52%275.523.5%$207.45m
BLUEBluebird Bio, Inc.
-4.74%160.9015.7%$185.09m
EXASExact Sciences Corporation
-3.36%64.1025.4%$174.89m
AAgilent Technologies, Inc.
-2.37%61.301.5%$174.20m
ALXNAlexion Pharmaceuticals, Inc.
-1.98%125.052.0%$156.77m
BMRNBioMarin Pharmaceutical Inc.
-4.02%95.054.4%$136.28m
INCYIncyte Corporation
-2.90%71.882.5%$129.41m

Company Profile

Alpine Immune Sciences, Inc. is a development-stage pharmaceutical company, which engages in the discovering of protein-based immunotherapies therapies targeting the immune synapse to treat cancer, autoimmune, and inflammatory disorders. It offers Immunotherapy, Immune Synapse, vIgD Platform Technology, and TIP Program. The company was founded on July 24, 2017 and is headquartered in Seattle, WA.